Company
Where nature, tradition, and technology meet.
Asia is our home — a land of extraordinary biodiversity and a long-standing tradition of natural healing. At NYB, we bridge the generational wisdom of nature with state-of-the-art AI technologies to accelerate the discovery of bioactive compounds.
Key metrics
- Compound library
- 2B+
- Natural compounds
- 10M+
- Higher hit rate
- 64x
- Bioactivity prediction efficiency
- 44.83%
Virtually screenable molecules accessible through our AI pipeline.
Plant-derived bioactives indexed for screening.
Improvement over the most popular molecular docking software.
Increase reported in our IEEE DTIGN paper versus baseline.
Vision and Mission
Our Vision
To shape a future where healthcare treatments are accessible, effective, and elevate the quality of life for all.
Our Mission
To unlock meaningful health and wellness solutions by transforming nature's insights through science, technology, and innovation.
Milestones
2022
Founding
Nanyang Biologics is incorporated in Singapore.
2024
DTIGN publication
Drug-Target Interaction Graph Neural Network published on IEEE Xplore.
2025
LigoSpace at NeurIPS 2025
LigoSpace, developed with NTU Singapore, presented at NeurIPS 2025.
2026
NVIDIA GTC 2026
Exhibited at NVIDIA GTC 2026, March 16–19.
Leadership
Scientific and operational leadership behind our discovery platform.
Roland Ong, PhD
Founder and Chairman
- PhD
TODO(content): bio.
Winifred Yau, PhD
Chief Executive Officer
- PhD
TODO(content): bio.
Yi Chieh Lim, PhD
Chief Scientific Officer
- PhD
TODO(content): bio.
Micheal Fong
Chief Strategy & Planning
TODO(content): bio.
Giang Nguyen
Chief Technology Officer
TODO(content): bio.
Duy Trieu
Director of Engineering
TODO(content): bio.
Quynh Nguyen
Senior AI Partnership Manager
TODO(content): bio.
Minh To
Innovation Manager
TODO(content): bio.
Vinh Nguyen
AI Engineer
TODO(content): bio.
Trang Nguyen
BD Associate
TODO(content): bio.